SCM
INSM icon

Semanteon Capital Management’s Insmed INSM Stock Holding History

Semanteon Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,455
Closed -$982K – 280
2024
Q3 		$982K Sell
13,455
-2,701
-17% -$199K 0.67% 68
2024
Q2 		$1.08M Buy
+16,156
New +$627K 0.77% 61

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Semanteon Capital Management's INSM Position: Q4 2024 in Review

Semanteon Capital Management sold out of Insmed (INSM) in Q4 2024, closing a stake of 13,455 shares — an estimated $982K sold.

Semanteon Capital Management first reported a position in INSM in Q2 2024 and held it in 2 quarters. The position peaked at $1.08M in Q2 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

  • Semanteon Capital Management reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 13,455 Insmed shares in Q4 2024, an estimated $982K.
  • Semanteon Capital Management first reported a position in Insmed in Q2 2024 and held it in 2 quarters.
  • Semanteon Capital Management's Insmed position peaked at $1.08M in Q2 2024.
  • 438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Semanteon Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.